The COVID-19 vaccine was developed and tested in multiple phases as required for all vaccines. Tens of thousands of people were given the vaccine during the tests, and effectiveness and safety was monitored for eight weeks. Before approving a vaccine, the Food and Drug Administration (FDA) independently and rigorously analyzes data from the clinical trial. Emergency Use Authorization (EUA) is not granted until this independent analysis is completed.